Haemonetics HAE Plasma — Total net revenues

Other product segments

Similar metrics at other companies

EXELNet product revenues — Total revenues

$554.98M+8.1%

VRTXProduct revenues, net — Product revenues, net

$2.99B+8.2%

SHCProduct — Total net revenues

$38.44M+25.7%

NBIXNet product sales — Total revenues

$811M+43.9%

RYTMProduct revenue, net — Total revenues

$60.11M+59.4%

EXELGross product revenues — Total revenues

$795.35M+10.2%

Questions, answered.

What is Haemonetics's plasma — total net revenues?

Haemonetics (HAE) reported plasma — total net revenues of $130.29M in Q1 2026.

How has Haemonetics's plasma — total net revenues changed year-over-year?

Haemonetics's plasma — total net revenues increased by 2.8% year-over-year, from $126.74M to $130.29M.

What is the long-term trend for Haemonetics's plasma — total net revenues?

Over 4 years (2022 to 2026), Haemonetics's plasma — total net revenues has grown at a 10.5% compound annual growth rate (CAGR), from $351.35M to $524.46M.

What does plasma — total net revenues mean?

Represents the total gross revenue generated from the sale of plasma-related products and services, net of returns, allowances, and discounts. This is the top-line figure for the plasma segment and serves as the primary gauge of market share and demand. It reflects the overall scale and commercial success of the company's plasma business operations.